Benazepril/Valsartan

DRUG2 trials

Sponsors

Mario Negri Institute for Pharmacological Research

Conditions

Diabetes

Phase 3

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes

CompletedNCT00494715

Mario Negri Institute for Pharmacological ResearchDiabetes

Start: 2007-05-31End: 2016-04-30Updated: 2016-06-01

Preventing Microalbuminuria in Type 2 Diabetes

CompletedNCT00503152

Mario Negri Institute for Pharmacological ResearchDiabetes

Start: 2007-05-31End: 2016-09-30Updated: 2019-09-06

Related Papers

Preventing microalbuminuria with benazepril, valsartan, and benazepril–valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study

PLoS Medicine2021-07-1411 citations